Business News • PR NewsWire • Nordic Nanovector: Abstracts of LYMRIT 37-01 Study With Betalutin® in NHL Patients and Other Studies Accepted for Poster Presentations at ASH

Nordic Nanovector: Abstracts of LYMRIT 37-01 Study With Betalutin® in NHL Patients and Other Studies Accepted for Poster Presentations at ASH

Nordic Nanovector: Abstracts of LYMRIT 37-01 Study With Betalutin® in NHL Patients and Other Studies Accepted for Poster Presentations at ASH

OSLO, Norway, Oct. 2, 2018 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANO) announces that an abstract reporting data from the Phase 1/2a LYMRIT 37-01 study investigating Betalutin® (177Lu-lilotomab satetraxetan) in patients with relapsed/refractory indolent non-Hodgkin's lymphoma (iNHL) ...

View More : https://www.prnewswire.com:443/news-releases/nordic-nanovector-abstracts-of-lymrit-37-01-study-with-betalutin-in-nhl-pat...

Releted News by prnewswire

Saba Software Announces Agreement to Acquire Lumesse, Accelerating its Global Leadership in Talent Development

Bonterra Intersects 37.5 g/t Au over 3.3 m at Gladiator Deposit

Epson Earns Five PRINT 18 RED HOT Technology Designations

Nordic Nanovector: Abstracts of LYMRIT 37-01 Study With Betalutin® in NHL Patients and Other Studies Accepted for Poster Presentations at ASH

Le Centre national de recherche sur les primates de Tulane reçoit le 100e système de PET préclinique de Mediso avec l'installation du MultiScan à très grand champ de vision et extrême résolution (LFER150) pour la PET et la CT

El Tulane National Primate Research Center recibe el sistema PET preclínico Mediso número 100

Global Routers, Switchers, and Master Controls Market, Forecast to 2023